Technical Update, Financial Results, Dividend Declaration, Availability of Vaccinations, and Upcoming Earnings Release - Research Reports on Wynn Resorts, DSW, Interpublic Group, Walgreens and Yum!

NEW YORK, August 29, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding Wynn Resorts Ltd. (NASDAQ: WYNN), DSW Inc. (NYSE: DSW), The Interpublic Group of Companies, Inc. (NYSE: IPG), Walgreen Co. (NYSE: WAG) and Yum! Brands, Inc. (NYSE: YUM). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/6073-100free.

--
Wynn Resorts Ltd. Research Reports
On August 26, 2014, the shares of Wynn Resorts Ltd. declined 0.59% to end the trading session at $199.28. After opening at $199.19, the stock oscillated in the range of $197.13 - $200.00. Over the last one month, the Company's stock has declined by 2.54%, compared to the Dow Jones Industrial Average which surged by 0.86% during the same period. The full research reports on Wynn Resorts are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/WYNN/report.pdf

--
DSW Inc. Research Reports
On August 26, 2014, DSW Inc. (DSW) announced its Q2 FY 2014 financial results (period ended August 2, 2014). Net sales for the quarter came in at $587.1 million, up 4.5% YoY. Net income was at $34.3 million, up 1.8% YoY. Diluted EPS stood at $0.38 as compared to $0.37 in Q2 FY 2013, and adjusted EPS for Q2 FY 2014 was reported at $0.37. For FY 2014, DSW expects adjusted EPS to vary from $1.50 to $1.65 per share. Mike MacDonald, President and CEO at DSW stated, "In the quarter we accomplished our goal of achieving improvement in the underlying sales trends and eliminating any inventory imbalances. All major categories recorded improved sales performance in the second quarter compared to the first quarter. In addition, we were encouraged by the sequential improvement in sales trends as the quarter progressed." In the same release DSW informed that on August 19, 2014, its Board of Directors approved a quarterly cash dividend payment of c.$0.19 per share, payable on September 30, 2014 to shareholders of record at the close of business on September 19, 2014. The full research reports on DSW are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/DSW/report.pdf

--
The Interpublic Group of Companies, Inc. Research Reports
On August 12, 2014, The Interpublic Group of Companies, Inc. announced that its Board of Directors has declared a quarterly dividend of $0.095 per share on Interpublic Group common stock. According to the Company, the dividend is payable on September 16, 2014 to shareholders of record at the close of business on September 2, 2014. The full research reports on Interpublic Group are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/IPG/report.pdf

--
Walgreen Co. Research Reports
On August 19, 2014, Walgreen Co.(Walgreens) reported that flu shots are available at all Walgreens pharmacies, Healthcare Clinics at select Walgreens and Duane Reade pharmacies in New York City, US, following a second severe flu season in the country. According to Walgreens, Flu shots are provided daily throughout all pharmacies with no appointment necessary at clinic hours, including nights, overnights at 24-hour pharmacy locations, weekends and holidays. Walgreens stated that age restrictions vary by state at Walgreens pharmacies, while Healthcare Clinics at select Walgreens can provide immunizations for patients age 2 and older. The full research reports on Walgreens are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/WAG/report.pdf

--
Yum! Brands, Inc. Research Reports
NASDAQ, reported that according to a methodology based on Yum! Brands, Inc.'s historical reporting dates, the Company is anticipated to release its Q3 FY 2014 results on October 14, 2014. According to Zacks Investment Research's the consensus EPS forecast for the quarter is $0.99. The full research reports on Yum! are available to download free of charge at:

http://www.analystsreview.com/Aug-29-2014/YUM/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED